Dual blockade of the renin-angiotensin system with angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs).
作者信息
Ritter J M
出版信息
Br J Clin Pharmacol. 2011 Mar;71(3):313-5. doi: 10.1111/j.1365-2125.2011.03918.x.
Abstract
摘要
相似文献
1
Dual blockade of the renin-angiotensin system with angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs).
Br J Clin Pharmacol. 2011 Mar;71(3):313-5. doi: 10.1111/j.1365-2125.2011.03918.x.
2
Optimal antagonism of the Renin-Angiotensin-aldosterone system: do we need dual or triple therapy?
Drugs. 2010 Jul 9;70(10):1215-30. doi: 10.2165/11537910-000000000-00000.
3
New approaches to blockade of the renin-angiotensin-aldosterone system: evidence from randomized controlled trials (RCTs) of angiotensin-converting enzyme inhibitors and angiotensin II-receptor blockers--questions remain unsolved.
J Pharmacol Sci. 2010;113(4):292-5. doi: 10.1254/jphs.10r08fm. Epub 2010 Jul 27.
4
Dual Blockade of the Renin-Angiotensin System: A Strategy that Should Be Reconsidered in Cardiorenal Diseases?
Nephron. 2021;145(2):99-106. doi: 10.1159/000513119. Epub 2021 Feb 5.
5
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for IgA nephropathy.
Semin Nephrol. 2004 May;24(3):218-24. doi: 10.1016/j.semnephrol.2004.01.003.
6
Resistant Hypertension On Treatment (ResHypOT): sequential nephron blockade compared to dual blockade of the renin-angiotensin-aldosterone system plus bisoprolol in the treatment of resistant arterial hypertension - study protocol for a randomized controlled trial.
Trials. 2018 Feb 12;19(1):101. doi: 10.1186/s13063-017-2343-3.
7
Should ACE inhibitors and ARBs be used in combination in children?
Pediatr Nephrol. 2019 Sep;34(9):1521-1532. doi: 10.1007/s00467-018-4046-8. Epub 2018 Aug 15.
8
Angiotensin receptor blockers are associated with lower mortality than ACE inhibitors in predialytic stage 5 chronic kidney disease: A nationwide study of therapy with renin-angiotensin system blockade.
PLoS One. 2017 Dec 7;12(12):e0189126. doi: 10.1371/journal.pone.0189126. eCollection 2017.
9
Angiotensin converting enzyme inhibitors and angiotensin receptor blockers in the treatment of hypertension: should they be used together?
Curr Vasc Pharmacol. 2010 Nov;8(6):742-6. doi: 10.2174/157016110793563924.
10
[Be careful when combining ACE inhibitors and angiotensin receptor blockers].
Praxis (Bern 1994). 2013 May 22;102(11):689-90. doi: 10.1024/1661-8157/a001302.
引用本文的文献
1
The benefits of angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers combined with calcium channel blockers on metabolic, renal, and cardiovascular outcomes in hypertensive patients: a meta-analysis.
Int Urol Nephrol. 2018 Dec;50(12):2261-2278. doi: 10.1007/s11255-018-1991-x. Epub 2018 Oct 15.
2
Angiotensin Converting Enzyme Regulates Cell Proliferation and Migration.
PLoS One. 2016 Dec 19;11(12):e0165371. doi: 10.1371/journal.pone.0165371. eCollection 2016.
3
Angiotensin II-regulated microRNA 483-3p directly targets multiple components of the renin-angiotensin system.
J Mol Cell Cardiol. 2014 Oct;75:25-39. doi: 10.1016/j.yjmcc.2014.06.008. Epub 2014 Jun 27.
本文引用的文献
1
Trends in co-prescribing of angiotensin converting enzyme inhibitors and angiotensin receptor blockers in Ireland.
Br J Clin Pharmacol. 2011 Mar;71(3):458-66. doi: 10.1111/j.1365-2125.2010.03835.x.
2
Aldosterone 'escape' vs 'breakthrough'.
Nat Rev Nephrol. 2010 Feb;6(2):61. doi: 10.1038/nrneph.2009.228.
3
The sudden demise of dual renin-angiotensin system blockade or the soft science of the surrogate end point.
J Am Coll Cardiol. 2009 Feb 10;53(6):468-70. doi: 10.1016/j.jacc.2008.10.036.
4
Telmisartan, ramipril, or both in patients at high risk for vascular events.
N Engl J Med. 2008 Apr 10;358(15):1547-59. doi: 10.1056/NEJMoa0801317. Epub 2008 Mar 31.
5
Meta-analysis: effect of monotherapy and combination therapy with inhibitors of the renin angiotensin system on proteinuria in renal disease.
Ann Intern Med. 2008 Jan 1;148(1):30-48. doi: 10.7326/0003-4819-148-1-200801010-00190. Epub 2007 Nov 5.
6
Mast cell tryptases and chymases in inflammation and host defense.
Immunol Rev. 2007 Jun;217:141-54. doi: 10.1111/j.1600-065X.2007.00509.x.
7
Systematic review of combined angiotensin-converting enzyme inhibition and angiotensin receptor blockade in hypertension.
Hypertension. 2005 May;45(5):880-6. doi: 10.1161/01.HYP.0000161880.59963.da. Epub 2005 Apr 4.
8
Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.
N Engl J Med. 2003 Nov 13;349(20):1893-906. doi: 10.1056/NEJMoa032292. Epub 2003 Nov 10.
9
Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.
N Engl J Med. 2003 Apr 3;348(14):1309-21. doi: 10.1056/NEJMoa030207. Epub 2003 Mar 31.
10
The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.
N Engl J Med. 1999 Sep 2;341(10):709-17. doi: 10.1056/NEJM199909023411001.
Zotero 插件